 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "CSPC Zhongrun" – news · newspapers · books · scholar · JSTOR (December 2018) (Learn how and when to remove this message) |
 | A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Misplaced Pages's content policies, particularly neutral point of view. Please discuss further on the talk page. (December 2018) (Learn how and when to remove this message) |
Hebei Zhongrun Pharmaceutical Co., Ltd (CSPC Zhongrun) (simplified Chinese: 石药集团河北中润制药有限公司; traditional Chinese: 石藥集團河北中潤制藥有限公司; pinyin: Shíyào jítuán héběi zhōngrùn zhìyào yǒuxiàn gōngsī) is one of China's largest producers of bulk antibiotic active pharmaceutical ingredients. CSPC Zhongrun produces both penicillin and cephalosporin series API.
A joint venture established in 1989 by China Pharmaceutical Group Ltd (CHINA PHARMA, SEHK: 1093), CSPC Zhongrun employs more than 3,600 workers.
CSPC Zhongrun penicillin and cephalosporin Beta-lactam antibiotic products include 16 varieties of API and intermediates. The penicillin series includes penicillin G potassium crude, penicillin G potassium, penicillin G sodium, 6-APA, amoxicillin trihydrate, ampicillin trihydrate and ampicillin sodium.
The cephalosporin series includes intermediate 7-ACA, cefazolin sodium, cefazolin acid and ceftriaxone sodium. Meropenem API is also produced.
External links
- CSPC Zhongrun official website at the Wayback Machine (archived January 5, 2009)
- CSPC Pharmaceutical Group official website
